Precision BioSciences Presents Preclinical PBGENE-DMD Data Highlighting Durable Dystrophin Expression and Functional Benefit at the Muscular Dystrophy Association Clinical & Scientific Conference
Go back to Precision BioSciences Presents Preclinical PBGENE-DMD Data Highlighting Durable Dystrophin Expression and Functional Benefit at the Muscular Dystrophy Association Clinical & Scientific Conference| (NASDAQ: DTIL) | Delayed: 7.88 +0.02 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.86 | 52 Week High | $ | |||
| Open | $7.96 | 52 Week Low | $ | |||
| Day High | $8.00 | P/E | N/A | |||
| Day Low | $7.55 | EPS | $ | |||
| Volume | 115,267 | |||||
